Generic Drugs Market (By Product Type: Simple Generics, Super Generics, Biosimilars; By Route of Administration: Oral, Topical, Injectable, Intra-venous, Others; By Application: Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drug, Respiratory Products, Others; By Distribution Channel: Hospitals, Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Generic Drugs
1.1. Definition and Scope 
1.1.1. Definition of Generic Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Generic Drugs Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Generic Drugs Market By Product Type
1.2.3. Generic Drugs Market By Route Of Administration
1.2.4. Generic Drugs Market By Application
1.2.5. Generic Drugs Market By Distribution Channel
1.2.6. Generic Drugs Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Generic Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Generic Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Distribution Channel Source of Generic Drugs Major Manufacturers in 2019

CHAPTER 5. Generic Drugs Market By Product Type
5.1. Introduction
5.2. Generic Drugs Revenue By Product Type
5.2.1. Generic Drugs Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
5.2.2. Simple Generics
5.2.2.1. Simple Generics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Super Generics
5.2.3.1. Super Generics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Biosimilars
5.2.4.1. Biosimilars Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Generic Drugs Market Revenue By Route Of Administration
6.1. Introduction
6.2. Generic Drugs Revenue (US$ Mn) By Route Of Administration
6.2.1. Generic Drugs Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
6.2.2. Oral
6.2.2.1. Oral Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Topical
6.2.3.1. Topical Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Injectable
6.2.4.1. Injectable Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Intra-venous
6.2.5.1. Intra-venous Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Others
6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Generic Drugs Market By Application 
7.1. Introduction
7.2. Generic Drugs Revenue (US$ Mn) By Application
7.2.1. Generic Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. Cardiovascular Products
7.2.2.1. Cardiovascular Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Anti-Infective Drugs
7.2.3.1. Anti-Infective Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Anti-Arthritis Drugs
7.2.4.1. Anti-Arthritis Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Central Nervous System Drugs
7.2.5.1. Central Nervous System Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.6. Anti-Cancer Drug
7.2.6.1. Anti-Cancer Drug Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.7. Respiratory Products
7.2.7.1. Respiratory Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.8. Others
7.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. Generic Drugs Market By Distribution Channel 
8.1. Introduction
8.2. Generic Drugs Revenue (US$) By Distribution Channel
8.2.1. Generic Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.3. Hospitals
8.3.1. Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.4. Pharmacies
8.4.1. Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.5. Others
8.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 9. North America Generic Drugs Market By Country 
9.1. North America Generic Drugs Overview
9.2. U.S.
9.2.1. U.S. Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.2.2. U.S. Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
9.2.3. U.S. Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.2.4. U.S. Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Canada
9.3.1. Canada Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.3.2. Canada Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
9.3.3. Canada Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3.4. Canada Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. North America PEST Analysis

CHAPTER 10. Europe Generic Drugs Market By Country
10.1. Europe Generic Drugs Market Overview
10.2. U.K.
10.2.1. U.K. Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
10.2.2. U.K. Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
10.2.3. U.K. Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
10.2.4. U.K. Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.3. Germany
10.3.1. Germany Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
10.3.2. Germany Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
10.3.3. Germany Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
10.3.4. Germany Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.4. France 
10.4.1. France Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
10.4.2. France Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
10.4.3. France Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
10.4.4. France Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.5. Spain
10.5.1. Spain Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
10.5.2. Spain Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
10.5.3. Spain Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
10.5.4. Spain Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.6. Rest of Europe
10.6.1. Rest of Europe Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
10.6.2. Rest of Europe Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016-2027
10.6.3. Rest of Europe Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
10.6.4. Rest of Europe Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Generic Drugs Market By Country
11.1. Asia Pacific Generic Drugs Market Overview
11.2. China
11.2.1. China Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.2.2. China Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.2.3. China Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.4. China Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. Japan
11.3.1. Japan Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.3.2. Japan Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.3.3. Japan Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.4. Japan Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. India
11.4.1. India Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.4.2. India Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.4.3. India Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.4. India Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.5. Australia
11.5.1. Australia Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.5.2. Australia Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.5.3. Australia Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.5.4. Australia Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.6. South Korea
11.6.1. South Korea Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.6.2. South Korea Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.6.3. South Korea Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.6.4. South Korea Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.7.2. Rest of Asia-Pacific Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
11.7.3. Rest of Asia-Pacific Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.7.4. Rest of Asia-Pacific Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Generic Drugs Market By Country
12.1. Latin America Generic Drugs Market Overview
12.2. Brazil
12.2.1. Brazil Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.2.2. Brazil Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
12.2.3. Brazil Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.2.4. Brazil Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.3. Mexico
12.3.1. Mexico Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.3.2. Mexico Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
12.3.3. Mexico Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3.4. Mexico Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.4. Rest of Latin America
12.4.1. Rest of Latin America Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.4.2. Rest of Latin America Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
12.4.3. Rest of Latin America Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4.4. Rest of Latin America Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Generic Drugs Market By Country 
13.1. Middle East & Africa Generic Drugs Market Overview
13.2. Saudi Arabia
13.2.1. Saudi Arabia Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
13.2.2. Saudi Arabia Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
13.2.3. Saudi Arabia Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
13.2.4. Saudi Arabia Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
13.3. UAE
13.3.1. UAE Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
13.3.2. UAE Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
13.3.3. UAE Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
13.3.4. UAE Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Generic Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
13.4.2. Rest of Middle East & Africa Generic Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2016 - 2027
13.4.3. Rest of Middle East & Africa Generic Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
13.4.4. Rest of Middle East & Africa Generic Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.5. Middle East & Africa PEST Analysis

CHAPTER 14. PLAYER ANALYSIS OF GENERIC DRUGS
14.1. Generic Drugs Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Generic Drugs Market

CHAPTER 15. COMPANY PROFILE
15.1. Abbott Laboratories 
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Mn), 2019
15.1.3.2. Abbott Laboratories  2019 Generic Drugs Business Regional Distribution
15.1.4. Product/ Service and Specification
15.1.5. Manufacturing Plant Footprint Analysis
15.2. Teva Pharmaceutical Industries Ltd.
15.3. ALLERGAN
15.4. Sandoz International GmbH
15.5. Mylan N.V.
15.6. STADA Arzneimittel AG
15.7. Baxter International Inc.
15.8. Eli Lilly and Company
15.9. GlaxoSmithKline Plc.
15.10. Pfizer Inc 
15.11. Others